id	sid	eid	entity	type
fnp-2627	1	1	ten	CARDINAL
fnp-2627	1	2	the year	DATE
fnp-2627	1	3	1:4	CARDINAL
fnp-2627	1	4	2020	DATE
fnp-2627	1	5	ten	CARDINAL
fnp-2627	1	6	the year	DATE
fnp-2627	1	7	marta margeta department of pathology	ORG
fnp-2627	1	8	university of california	ORG
fnp-2627	1	9	san francisco	GPE
fnp-2627	1	10	marta margeta	PERSON
fnp-2627	1	11	ucsf pathology	PERSON
fnp-2627	1	12	0511	DATE
fnp-2627	2	1	513 parnassus ave	QUANTITY
fnp-2627	2	2	san francisco	GPE
fnp-2627	2	3	94143	DATE
fnp-2627	3	1	15 january 2020	DATE
fnp-2627	3	2	21 january 2020	DATE
fnp-2627	4	1	23	CARDINAL
fnp-2627	4	2	ten	CARDINAL
fnp-2627	4	3	first	ORDINAL
fnp-2627	4	4	2019	DATE
fnp-2627	4	5	that year	DATE
fnp-2627	6	1	myoglobinopathy	PERSON
fnp-2627	6	2	popdc3	PERSON
fnp-2627	8	1	aav	PRODUCT
fnp-2627	8	2	afm	PERSON
fnp-2627	8	3	casa	ORG
fnp-2627	8	4	dm	ORG
fnp-2627	8	5	ema	ORG
fnp-2627	8	6	european medicines	ORG
fnp-2627	8	7	ev	ORG
fnp-2627	8	8	fda	ORG
fnp-2627	8	9	federal drug administration	ORG
fnp-2627	8	10	3	CARDINAL
fnp-2627	8	11	imnm	PERSON
fnp-2627	8	12	irae	GPE
fnp-2627	8	13	irneuropathy	ORG
fnp-2627	8	14	mhc	ORG
fnp-2627	8	15	msa	ORG
fnp-2627	8	16	nemaline	NORP
fnp-2627	8	17	sibm	GPE
fnp-2627	8	18	srp	ORG
fnp-2627	8	19	2019	DATE
fnp-2627	8	20	an exciting year	DATE
fnp-2627	9	1	ten 2019	CARDINAL
fnp-2627	9	2	four	CARDINAL
fnp-2627	11	1	1	CARDINAL
fnp-2627	11	2	two	CARDINAL
fnp-2627	11	3	first	ORDINAL
fnp-2627	11	4	2019	DATE
fnp-2627	12	1	myoglobinopathy	PERSON
fnp-2627	12	2	c.292c	CARDINAL
fnp-2627	12	3	1	CARDINAL
fnp-2627	12	4	2019	DATE
fnp-2627	13	1	two	CARDINAL
fnp-2627	13	2	two	CARDINAL
fnp-2627	13	3	14	CARDINAL
fnp-2627	13	4	six	CARDINAL
fnp-2627	14	1	myoglobinopathy	PERSON
fnp-2627	14	2	the fourth to fifth decade	DATE
fnp-2627	15	1	approximately half	CARDINAL
fnp-2627	16	1	two	CARDINAL
fnp-2627	16	2	1	CARDINAL
fnp-2627	19	1	1	CARDINAL
fnp-2627	23	1	one	CARDINAL
fnp-2627	25	1	32s	CARDINAL
fnp-2627	25	2	31p	CARDINAL
fnp-2627	28	1	2 µm	DATE
fnp-2627	28	2	5 µm	DATE
fnp-2627	28	3	0.5 µm	CARDINAL
fnp-2627	28	4	1 µm	DATE
fnp-2627	28	5	4 µm	CARDINAL
fnp-2627	29	1	5	CARDINAL
fnp-2627	29	2	2019	DATE
fnp-2627	29	3	4.0	CARDINAL
fnp-2627	30	1	popdc3	PERSON
fnp-2627	30	2	5	CARDINAL
fnp-2627	30	3	3	CARDINAL
fnp-2627	30	4	1500	CARDINAL
fnp-2627	30	5	2019	DATE
fnp-2627	31	1	popdc3	PERSON
fnp-2627	31	2	3	CARDINAL
fnp-2627	32	1	popdc3	PERSON
fnp-2627	32	2	two	CARDINAL
fnp-2627	32	3	popdc1	PERSON
fnp-2627	32	4	popdc2	PERSON
fnp-2627	32	5	2019	DATE
fnp-2627	32	6	2019	DATE
fnp-2627	34	1	2	CARDINAL
fnp-2627	34	2	2019	DATE
fnp-2627	34	3	two	CARDINAL
fnp-2627	36	1	johansen et al.	PERSON
fnp-2627	36	2	2019	DATE
fnp-2627	36	3	mohn et al.	PERSON
fnp-2627	36	4	2019	DATE
fnp-2627	36	5	psimaras et al.	PERSON
fnp-2627	36	6	2019	DATE
fnp-2627	38	1	up to 25%	PERCENT
fnp-2627	38	2	more than one	CARDINAL
fnp-2627	38	3	2019	DATE
fnp-2627	39	1	2019	DATE
fnp-2627	39	2	mohn et al.	PERSON
fnp-2627	39	3	2019	DATE
fnp-2627	40	1	2018	DATE
fnp-2627	41	1	2018	DATE
fnp-2627	41	2	johansen et al.	PERSON
fnp-2627	41	3	2019	DATE
fnp-2627	41	4	mohn et al.	PERSON
fnp-2627	41	5	2019	DATE
fnp-2627	42	1	irae	GPE
fnp-2627	42	2	pembrolizumab	PERSON
fnp-2627	42	3	mohn et al.	GPE
fnp-2627	42	4	2019	DATE
fnp-2627	43	1	2019	DATE
fnp-2627	44	1	cd8+	LOC
fnp-2627	44	2	cd68	PRODUCT
fnp-2627	45	1	2018	DATE
fnp-2627	45	2	fig	ORG
fnp-2627	46	1	2	CARDINAL
fnp-2627	47	1	2019	DATE
fnp-2627	48	1	2	CARDINAL
fnp-2627	51	1	approximately 6 weeks	DATE
fnp-2627	52	1	100	CARDINAL
fnp-2627	52	2	50	CARDINAL
fnp-2627	53	1	recent years	DATE
fnp-2627	54	1	2019	DATE
fnp-2627	54	2	one	CARDINAL
fnp-2627	55	1	sloan et al.	PERSON
fnp-2627	55	2	2019	DATE
fnp-2627	56	1	3	CARDINAL
fnp-2627	58	1	sloan et al.	PERSON
fnp-2627	58	2	2019	DATE
fnp-2627	60	1	3	CARDINAL
fnp-2627	60	2	al.	PERSON
fnp-2627	60	3	2018	DATE
fnp-2627	61	1	afm	PERSON
fnp-2627	61	2	the 1950s	DATE
fnp-2627	62	1	afm	PERSON
fnp-2627	62	2	1970-90	DATE
fnp-2627	62	3	ev-a71	ORG
fnp-2627	62	4	al.	PERSON
fnp-2627	62	5	2018	DATE
fnp-2627	62	6	al.	ORG
fnp-2627	62	7	2018	DATE
fnp-2627	63	1	2012	DATE
fnp-2627	63	2	afm	PERSON
fnp-2627	64	1	first	ORDINAL
fnp-2627	64	2	california	GPE
fnp-2627	64	3	5-7 days	DATE
fnp-2627	64	4	3-9 years of age	DATE
fnp-2627	64	5	every other year	DATE
fnp-2627	64	6	the summer/fall season	DATE
fnp-2627	65	1	500	CARDINAL
fnp-2627	65	2	us	GPE
fnp-2627	65	3	schubert et al.	PERSON
fnp-2627	65	4	2019	DATE
fnp-2627	66	1	2014	DATE
fnp-2627	66	2	prior to 2008	DATE
fnp-2627	66	3	al.	PERSON
fnp-2627	66	4	2018	DATE
fnp-2627	67	1	nine	CARDINAL
fnp-2627	67	2	afm	PERSON
fnp-2627	67	3	dyda et al.	PERSON
fnp-2627	67	4	2018	DATE
fnp-2627	67	5	al.	ORG
fnp-2627	67	6	2018	DATE
fnp-2627	68	1	afm	PERSON
fnp-2627	68	2	2014	DATE
fnp-2627	68	3	1962	DATE
fnp-2627	68	4	hixon et al.	PERSON
fnp-2627	68	5	2017	DATE
fnp-2627	69	1	2016	CARDINAL
fnp-2627	69	2	afm	PERSON
fnp-2627	69	3	dyda et al.	PERSON
fnp-2627	69	4	2018	DATE
fnp-2627	70	1	ev	ORG
fnp-2627	70	2	more than half	CARDINAL
fnp-2627	70	3	ev rna	PERSON
fnp-2627	70	4	2019	DATE
fnp-2627	70	5	afm	PERSON
fnp-2627	71	1	2019	CARDINAL
fnp-2627	71	2	schubert et al	PERSON
fnp-2627	71	3	42 afm	QUANTITY
fnp-2627	71	4	2012-2018	DATE
fnp-2627	71	5	58	CARDINAL
fnp-2627	72	1	one	CARDINAL
fnp-2627	73	1	anti-ev	NORP
fnp-2627	74	1	more than one	CARDINAL
fnp-2627	74	2	afm	PERSON
fnp-2627	75	1	csf ev	PERSON
fnp-2627	75	2	schubert et al.	PERSON
fnp-2627	75	3	2019	DATE
fnp-2627	76	1	3	CARDINAL
fnp-2627	77	1	neurofilament immunohistochemistry	ORG
fnp-2627	78	1	sloan et al.	PERSON
fnp-2627	78	2	2019	DATE
fnp-2627	79	1	100	CARDINAL
fnp-2627	79	2	4	CARDINAL
fnp-2627	80	1	1	CARDINAL
fnp-2627	80	2	nemaline	NORP
fnp-2627	82	1	2019	DATE
fnp-2627	83	1	2019	DATE
fnp-2627	83	2	2019	DATE
fnp-2627	83	3	al.	GPE
fnp-2627	83	4	2020	DATE
fnp-2627	83	5	ross et al.	PERSON
fnp-2627	83	6	2019	DATE
fnp-2627	83	7	two	CARDINAL
fnp-2627	84	1	nemaline	NORP
fnp-2627	84	2	at least 13	CARDINAL
fnp-2627	85	1	al	ORG
fnp-2627	85	2	2020	DATE
fnp-2627	85	3	2019	DATE
fnp-2627	85	4	13	CARDINAL
fnp-2627	85	5	nem6 subtype	ORG
fnp-2627	85	6	kbtbd13	PERSON
fnp-2627	86	1	nem6	PERSON
fnp-2627	87	1	8:1	CARDINAL
fnp-2627	87	2	7:1	CARDINAL
fnp-2627	89	1	nemaline	NORP
fnp-2627	90	1	2019	DATE
fnp-2627	90	2	ross et al.	PERSON
fnp-2627	90	3	2019	DATE
fnp-2627	91	1	two	CARDINAL
fnp-2627	93	1	4	CARDINAL
fnp-2627	94	1	4	CARDINAL
fnp-2627	98	1	2 µm	DATE
fnp-2627	98	2	4 µm. 5	DATE
fnp-2627	98	3	the age of 50	DATE
fnp-2627	99	1	sibm	ORG
fnp-2627	100	1	5a	CARDINAL
fnp-2627	100	2	sibm	LOC
fnp-2627	100	3	sibm pathogenesis.three	FAC
fnp-2627	100	4	2019	DATE
fnp-2627	100	5	2019	DATE
fnp-2627	100	6	greenberg et al.	PERSON
fnp-2627	100	7	2019	DATE
fnp-2627	100	8	knauss et al.	PERSON
fnp-2627	100	9	2019	DATE
fnp-2627	100	10	sibm	LOC
fnp-2627	100	11	greenberg et al.	PERSON
fnp-2627	100	12	2019	DATE
fnp-2627	100	13	knauss et al.	PERSON
fnp-2627	100	14	2019	DATE
fnp-2627	100	15	2019	DATE
fnp-2627	100	16	two	CARDINAL
fnp-2627	100	17	2019	DATE
fnp-2627	101	1	cd57	ORG
fnp-2627	101	2	klrg1	PERSON
fnp-2627	101	3	g1	ORG
fnp-2627	102	1	two	CARDINAL
fnp-2627	102	2	sibm	LOC
fnp-2627	103	1	5	CARDINAL
fnp-2627	103	2	imnm	PERSON
fnp-2627	103	3	sibm	GPE
fnp-2627	104	1	imnm	PERSON
fnp-2627	106	1	50	CARDINAL
fnp-2627	107	1	sibm pathogenesis	ORG
fnp-2627	108	1	greenberg at al	PERSON
fnp-2627	109	1	2019	DATE
fnp-2627	109	2	10	CARDINAL
fnp-2627	110	1	1975	DATE
fnp-2627	110	2	bohan & peter	ORG
fnp-2627	110	3	imnm	PERSON
fnp-2627	110	4	al.	PERSON
fnp-2627	110	5	2017	CARDINAL
fnp-2627	110	6	tanboon	TIME
fnp-2627	110	7	nishino	GPE
fnp-2627	110	8	2019	DATE
fnp-2627	111	1	greenberg	PERSON
fnp-2627	111	2	sibm	ORG
fnp-2627	111	3	cd8+	ORG
fnp-2627	111	4	cd57	ORG
fnp-2627	111	5	cd57	ORG
fnp-2627	112	1	sibm	LOC
fnp-2627	114	1	klrg1	GPE
fnp-2627	114	2	sibm	ORG
fnp-2627	114	3	greenberg et al.	PERSON
fnp-2627	114	4	2019	DATE
fnp-2627	115	1	6	CARDINAL
fnp-2627	115	2	2016	DATE
fnp-2627	115	3	al.	PERSON
fnp-2627	115	4	2018	DATE
fnp-2627	116	1	3-hydroxy-3-methylglutaryl	QUANTITY
fnp-2627	116	2	approximately one third	CARDINAL
fnp-2627	116	3	2019	DATE
fnp-2627	118	1	5d	CARDINAL
fnp-2627	118	2	mhc-1	ORG
fnp-2627	119	1	anti-srp	NORP
fnp-2627	119	2	al.	GPE
fnp-2627	119	3	2017	DATE
fnp-2627	120	1	2019	DATE
fnp-2627	120	2	two	CARDINAL
fnp-2627	120	3	imnm	PERSON
fnp-2627	120	4	bergua et al.	PERSON
fnp-2627	120	5	2019	DATE
fnp-2627	121	1	anti-srp	NORP
fnp-2627	123	1	two	CARDINAL
fnp-2627	123	2	imnm	PERSON
fnp-2627	123	3	54 kda	QUANTITY
fnp-2627	123	4	srp	ORG
fnp-2627	123	5	2019	DATE
fnp-2627	125	1	2019	CARDINAL
fnp-2627	125	2	2019	DATE
fnp-2627	127	1	5b	CARDINAL
fnp-2627	127	2	5c	CARDINAL
fnp-2627	127	3	2019	DATE
fnp-2627	127	4	imnm	PERSON
fnp-2627	128	1	5e	CARDINAL
fnp-2627	128	2	5f	CARDINAL
fnp-2627	130	1	2019	DATE
fnp-2627	131	1	7	CARDINAL
fnp-2627	131	2	four	CARDINAL
fnp-2627	131	3	dm	ORG
fnp-2627	131	4	imnm	PERSON
fnp-2627	131	5	sibm	ORG
fnp-2627	131	6	first	ORDINAL
fnp-2627	131	7	al	ORG
fnp-2627	132	1	2017	CARDINAL
fnp-2627	132	2	tanboon	TIME
fnp-2627	132	3	nishino	GPE
fnp-2627	132	4	2019	DATE
fnp-2627	133	1	the last 5-10 years	DATE
fnp-2627	133	2	msa	ORG
fnp-2627	133	3	6	MONEY
fnp-2627	134	1	msa	ORG
fnp-2627	135	1	two	CARDINAL
fnp-2627	135	2	large european iim	ORG
fnp-2627	135	3	2019	DATE
fnp-2627	135	4	msa	ORG
fnp-2627	135	5	40-60%	PERCENT
fnp-2627	135	6	2019	DATE
fnp-2627	135	7	montagnese	NORP
fnp-2627	135	8	2019	DATE
fnp-2627	135	9	msa	ORG
fnp-2627	135	10	more than one	CARDINAL
fnp-2627	135	11	msa	ORG
fnp-2627	135	12	msa	ORG
fnp-2627	136	1	6	CARDINAL
fnp-2627	137	1	dermatomyositis	GPE
fnp-2627	138	1	anti-mi-2	NORP
fnp-2627	138	2	dm	ORG
fnp-2627	140	1	three	CARDINAL
fnp-2627	141	1	100	CARDINAL
fnp-2627	142	1	dm	ORG
fnp-2627	142	2	imnm	GPE
fnp-2627	142	3	sibm	ORG
fnp-2627	142	4	tanboon	TIME
fnp-2627	142	5	nishino	PERSON
fnp-2627	142	6	2019	DATE
fnp-2627	143	1	fig	ORG
fnp-2627	143	2	6a	CARDINAL
fnp-2627	143	3	imnm	PERSON
fnp-2627	144	1	6c	CARDINAL
fnp-2627	144	2	anti-mi-2	NORP
fnp-2627	144	3	6b	CARDINAL
fnp-2627	145	1	two	CARDINAL
fnp-2627	145	2	2019	DATE
fnp-2627	145	3	pinal-fernandez et al.	ORG
fnp-2627	145	4	2019	DATE
fnp-2627	145	5	2019	DATE
fnp-2627	146	1	anti-mi-2	NORP
fnp-2627	146	2	inf1	NORP
fnp-2627	147	1	dm	GPE
fnp-2627	147	2	nishino	GPE
fnp-2627	147	3	2019	DATE
fnp-2627	148	1	sibm	ORG
fnp-2627	148	2	mhc-ii	ORG
fnp-2627	148	3	2019	DATE
fnp-2627	148	4	anti-mi-2-dm	PRODUCT
fnp-2627	149	1	dm muscle biopsies	ORG
fnp-2627	149	2	pinal-fernandez et al.	ORG
fnp-2627	149	3	2019	DATE
fnp-2627	149	4	2019	DATE
fnp-2627	149	5	mhc-ii	PRODUCT
fnp-2627	150	1	mhc-ii	PRODUCT
fnp-2627	150	2	dm	ORG
fnp-2627	151	1	imnm	PERSON
fnp-2627	151	2	pinal-fernandez et al.	ORG
fnp-2627	151	3	2019	DATE
fnp-2627	151	4	2019	DATE
fnp-2627	152	1	mhc-ii	PRODUCT
fnp-2627	154	1	mhc-ii	PRODUCT
fnp-2627	154	2	sibm	ORG
fnp-2627	154	3	2019	DATE
fnp-2627	155	1	8	CARDINAL
fnp-2627	156	1	50-75%	PERCENT
fnp-2627	156	2	2017	DATE
fnp-2627	156	3	intronic	GPE
fnp-2627	156	4	gonorazky et al.	PERSON
fnp-2627	156	5	2019	DATE
fnp-2627	158	1	36%	PERCENT
fnp-2627	158	2	gonorazky et al.	PERSON
fnp-2627	158	3	2019	DATE
fnp-2627	158	4	35%	PERCENT
fnp-2627	158	5	2017	CARDINAL
fnp-2627	158	6	2017	DATE
fnp-2627	160	1	gonorazky et al.	PERSON
fnp-2627	160	2	2019	DATE
fnp-2627	162	1	gonorazky et al.	PERSON
fnp-2627	162	2	2019	DATE
fnp-2627	164	1	french	NORP
fnp-2627	164	2	1	CARDINAL
fnp-2627	164	3	2	CARDINAL
fnp-2627	164	4	reyes-fernandez et al.	ORG
fnp-2627	164	5	2019	DATE
fnp-2627	165	1	2	CARDINAL
fnp-2627	165	2	reyes-fernandez et al.	ORG
fnp-2627	165	3	2019	DATE
fnp-2627	167	1	2019	CARDINAL
fnp-2627	167	2	congress	ORG
fnp-2627	167	3	kabeya et al.	FAC
fnp-2627	167	4	2019	DATE
fnp-2627	171	1	decades	DATE
fnp-2627	171	2	2019	DATE
fnp-2627	172	1	2019	DATE
fnp-2627	173	1	9	CARDINAL
fnp-2627	173	2	the first 6 months of age	DATE
fnp-2627	173	3	second	ORDINAL
fnp-2627	173	4	third decade	DATE
fnp-2627	173	5	sma4	PERSON
fnp-2627	174	1	sma	ORG
fnp-2627	174	2	1	CARDINAL
fnp-2627	174	3	smn2	ORG
fnp-2627	174	4	7	CARDINAL
fnp-2627	175	1	first	ORDINAL
fnp-2627	175	2	2016	DATE
fnp-2627	175	3	europe	LOC
fnp-2627	175	4	2017	CARDINAL
fnp-2627	175	5	sma1	PERSON
fnp-2627	176	1	2019	DATE
fnp-2627	177	1	smn2	ORG
fnp-2627	177	2	7	CARDINAL
fnp-2627	178	1	smn2	ORG
fnp-2627	178	2	ema	ORG
fnp-2627	178	3	european	NORP
fnp-2627	179	1	aav9	GPE
fnp-2627	179	2	avxs-101 or zolgensma	FAC
fnp-2627	179	3	aav9	GPE
fnp-2627	179	4	9	CARDINAL
fnp-2627	179	5	fda	ORG
fnp-2627	179	6	federal drug administration	ORG
fnp-2627	179	7	may 2019	DATE
fnp-2627	179	8	al-zaidy	ORG
fnp-2627	179	9	2019	DATE
fnp-2627	182	1	avxs-101	ORG
fnp-2627	182	2	2019	DATE
fnp-2627	183	1	two	CARDINAL
fnp-2627	184	1	two	CARDINAL
fnp-2627	186	1	2019	DATE
fnp-2627	187	1	2019	DATE
fnp-2627	187	2	3 months before to 3 months	DATE
fnp-2627	187	3	ramos et al.	PERSON
fnp-2627	187	4	2019	DATE
fnp-2627	187	5	2019	DATE
fnp-2627	188	1	2019	DATE
fnp-2627	189	1	10	CARDINAL
fnp-2627	190	1	three	CARDINAL
fnp-2627	190	2	fda	ORG
fnp-2627	190	3	ema	ORG
fnp-2627	190	4	vita et al.	PERSON
fnp-2627	190	5	2019	DATE
fnp-2627	191	1	ataluren	PERSON
fnp-2627	191	2	10-15%	PERCENT
fnp-2627	191	3	ema	ORG
fnp-2627	191	4	2014	DATE
fnp-2627	192	1	two	CARDINAL
fnp-2627	193	1	51	CARDINAL
fnp-2627	193	2	13%	PERCENT
fnp-2627	193	3	fda	ORG
fnp-2627	193	4	2016	DATE
fnp-2627	193	5	ema	ORG
fnp-2627	193	6	2019	DATE
fnp-2627	193	7	3	CARDINAL
fnp-2627	194	1	golodirsen	PERSON
fnp-2627	194	2	53	CARDINAL
fnp-2627	194	3	8%	PERCENT
fnp-2627	194	4	fda	ORG
fnp-2627	194	5	december 2019	DATE
fnp-2627	194	6	12/26/2019	DATE
fnp-2627	194	7	45	CARDINAL
fnp-2627	194	8	8%	PERCENT
fnp-2627	194	9	51	CARDINAL
fnp-2627	194	10	2019	DATE
fnp-2627	195	1	hwang	ORG
fnp-2627	195	2	yokota	GPE
fnp-2627	195	3	2019	DATE
fnp-2627	196	1	pompe	GPE
fnp-2627	196	2	1	CARDINAL
fnp-2627	196	3	pompe	GPE
fnp-2627	196	4	second	ORDINAL
fnp-2627	196	5	pompe	GPE
fnp-2627	196	6	2019	DATE
fnp-2627	198	1	us	GPE
fnp-2627	198	2	750,000	MONEY
fnp-2627	198	3	the first year	DATE
fnp-2627	198	4	375,000	MONEY
fnp-2627	202	1	michael lawlor	PERSON
fnp-2627	202	2	nigel g. laing	PERSON
fnp-2627	202	3	benedikt	GPE
fnp-2627	202	4	emily sloan	PERSON
fnp-2627	202	5	christine lin	PERSON
fnp-2627	204	1	n.	PERSON
fnp-2627	204	2	2019	DATE
fnp-2627	205	1	the united states	GPE
fnp-2627	205	2	europe	LOC
fnp-2627	206	1	29	CARDINAL
fnp-2627	206	2	13	CARDINAL
fnp-2627	207	1	h.h.	GPE
fnp-2627	207	2	w.	PERSON
fnp-2627	207	3	2017	CARDINAL
fnp-2627	209	1	neurobiol 43	LAW
fnp-2627	209	2	62-81	CARDINAL
fnp-2627	210	1	a.l.	GPE
fnp-2627	210	2	benveniste	GPE
fnp-2627	210	3	stenzel	GPE
fnp-2627	210	4	w.	PERSON
fnp-2627	210	5	2018	DATE
fnp-2627	211	1	224th	ORG
fnp-2627	211	2	netherlands	GPE
fnp-2627	211	3	14	CARDINAL
fnp-2627	212	1	neuromuscul disord	PERSON
fnp-2627	212	2	28	CARDINAL
fnp-2627	212	3	87	CARDINAL
fnp-2627	213	1	c., salem	GPE
fnp-2627	213	2	j.e.	GPE
fnp-2627	213	3	lebrun-vignes	ORG
fnp-2627	213	4	b.	PERSON
fnp-2627	213	5	johnson	PERSON
fnp-2627	213	6	d.b.	GPE
fnp-2627	213	7	a.l.	GPE
fnp-2627	213	8	stenzel	GPE
fnp-2627	213	9	w.	PERSON
fnp-2627	213	10	leonard-louis	PERSON
fnp-2627	213	11	s.	GPE
fnp-2627	213	12	benveniste	GPE
fnp-2627	213	13	j.j.	GPE
fnp-2627	213	14	2018	DATE
fnp-2627	215	1	138	CARDINAL
fnp-2627	215	2	743	CARDINAL
fnp-2627	216	1	al-zaidy	ORG
fnp-2627	216	2	s.a.	GPE
fnp-2627	216	3	j.r.	PERSON
fnp-2627	216	4	2019	DATE
fnp-2627	217	1	1	CARDINAL
fnp-2627	217	2	100	CARDINAL
fnp-2627	217	3	3-11	CARDINAL
fnp-2627	217	4	arouche	ORG
fnp-2627	217	5	l.	GPE
fnp-2627	217	6	amelin	GPE
fnp-2627	217	7	d.	NORP
fnp-2627	217	8	w.	PERSON
fnp-2627	217	9	g.d.	GPE
fnp-2627	217	10	boyer	PERSON
fnp-2627	217	11	stenzel	GPE
fnp-2627	217	12	w.	PERSON
fnp-2627	218	1	2017	CARDINAL
fnp-2627	219	1	anti-3-hydroxy-3-methylglutaryl	PERSON
fnp-2627	220	1	ann neurol 81	PERSON
fnp-2627	220	2	538	CARDINAL
fnp-2627	221	1	bergua	PERSON
fnp-2627	221	2	c.	GPE
fnp-2627	221	3	l.	GPE
fnp-2627	221	4	arnoult	GPE
fnp-2627	221	5	jean	PERSON
fnp-2627	221	6	zoubairi	GPE
fnp-2627	221	7	r.	NORP
fnp-2627	221	8	mahler	PERSON
fnp-2627	221	9	m.	PERSON
fnp-2627	221	10	2019	DATE
fnp-2627	222	1	anti-srp	NORP
fnp-2627	223	1	ann rheum dis 78	PERSON
fnp-2627	223	2	131	CARDINAL
fnp-2627	224	1	betteridge	ORG
fnp-2627	224	2	z.	PERSON
fnp-2627	224	3	tansley	ORG
fnp-2627	224	4	s.	PERSON
fnp-2627	224	5	shaddick	PERSON
fnp-2627	224	6	r.g.	GPE
fnp-2627	224	7	r.p.	GPE
fnp-2627	224	8	j.b.	GPE
fnp-2627	224	9	vencovsky	ORG
fnp-2627	224	10	j.	PERSON
fnp-2627	224	11	l.	PERSON
fnp-2627	224	12	danko	PERSON
fnp-2627	224	13	k.	PERSON
fnp-2627	225	1	2019	DATE
fnp-2627	226	1	european	NORP
fnp-2627	227	1	j autoimmun 101	PERSON
fnp-2627	227	2	48	CARDINAL
fnp-2627	228	1	b.b.	GPE
fnp-2627	228	2	marshall	PERSON
fnp-2627	228	3	j.l.	GPE
fnp-2627	228	4	tukiainen	ORG
fnp-2627	228	5	donkervoort	GPE
fnp-2627	228	6	s.	GPE
fnp-2627	228	7	foley	GPE
fnp-2627	228	8	a.r.	GPE
fnp-2627	228	9	waddell	GPE
fnp-2627	228	10	l.b.	GPE
fnp-2627	228	11	sandaradura	GPE
fnp-2627	228	12	s.a.	GPE
fnp-2627	228	13	o'grady	GPE
fnp-2627	228	14	g.l.	GPE
fnp-2627	228	15	2017	CARDINAL
fnp-2627	230	1	sci transl	ORG
fnp-2627	230	2	9	CARDINAL
fnp-2627	231	1	dabbous	PERSON
fnp-2627	231	2	jansen	PERSON
fnp-2627	231	3	j.p.	GPE
fnp-2627	231	4	m.	PERSON
fnp-2627	231	5	m., guerin, a.	PERSON
fnp-2627	231	6	i.	GPE
fnp-2627	231	7	wu	PERSON
fnp-2627	231	8	e.q.	PERSON
fnp-2627	231	9	arjunji	PERSON
fnp-2627	231	10	r.	NORP
fnp-2627	231	11	d.	NORP
fnp-2627	232	1	2019	DATE
fnp-2627	233	1	1	CARDINAL
fnp-2627	234	1	36	CARDINAL
fnp-2627	234	2	1164-1176	DATE
fnp-2627	235	1	a.	PERSON
fnp-2627	235	2	e.f.	GPE
fnp-2627	235	3	l.	PERSON
fnp-2627	236	1	2019	CARDINAL
fnp-2627	237	1	244th	ORG
fnp-2627	237	2	10-12	CARDINAL
fnp-2627	237	3	2019	DATE
fnp-2627	237	4	hoofdorp	ORG
fnp-2627	237	5	netherlands	GPE
fnp-2627	238	1	neuromuscul disord	PERSON
fnp-2627	239	1	de ridder	PERSON
fnp-2627	239	2	w.	GPE
fnp-2627	239	3	nelson	PERSON
fnp-2627	239	4	i.	PERSON
fnp-2627	239	5	asselbergh	PERSON
fnp-2627	239	6	b.	PERSON
fnp-2627	239	7	beuvin	GPE
fnp-2627	239	8	m., ben yaou	PERSON
fnp-2627	239	9	r.	NORP
fnp-2627	239	10	masson	PERSON
fnp-2627	239	11	a.	PERSON
fnp-2627	239	12	deleuze	GPE
fnp-2627	239	13	j.f.	GPE
fnp-2627	239	14	maisonobe	ORG
fnp-2627	239	15	2019	DATE
fnp-2627	241	1	5	CARDINAL
fnp-2627	241	2	d.c.	GPE
fnp-2627	241	3	bertini	PERSON
fnp-2627	241	4	e.	PERSON
fnp-2627	241	5	swoboda	PERSON
fnp-2627	241	6	k.j.	GPE
fnp-2627	241	7	w.l.	GPE
fnp-2627	241	8	crawford	GPE
fnp-2627	241	9	t.o.	PERSON
fnp-2627	241	10	finkel	PERSON
fnp-2627	241	11	r.s.	PERSON
fnp-2627	241	12	kirschner	PERSON
fnp-2627	241	13	j., kuntz	PERSON
fnp-2627	241	14	n.l.	GPE
fnp-2627	241	15	parsons	PERSON
fnp-2627	241	16	j.a.	GPE
fnp-2627	241	17	ryan	PERSON
fnp-2627	241	18	m.m.	PERSON
fnp-2627	242	1	2019	DATE
fnp-2627	243	1	nusinersen	PERSON
fnp-2627	243	2	2	CARDINAL
fnp-2627	244	1	29	CARDINAL
fnp-2627	244	2	842	CARDINAL
fnp-2627	245	1	j.m.	GPE
fnp-2627	245	2	molenaar	PERSON
fnp-2627	245	3	j.p.	GPE
fnp-2627	245	4	yuen	PERSON
fnp-2627	245	5	m., van der pijl	PERSON
fnp-2627	245	6	r.	NORP
fnp-2627	245	7	shen	GPE
fnp-2627	245	8	s.	PERSON
fnp-2627	245	9	conijn	GPE
fnp-2627	245	10	s.	PERSON
fnp-2627	245	11	van de locht	PERSON
fnp-2627	245	12	willigenburg	PERSON
fnp-2627	245	13	m.	PERSON
fnp-2627	245	14	s.j.	GPE
fnp-2627	245	15	van kleef	PERSON
fnp-2627	245	16	e.s.	GPE
fnp-2627	246	1	2020	DATE
fnp-2627	247	1	kbtbd13	PERSON
fnp-2627	248	1	j clin invest	PERSON
fnp-2627	249	1	dyda, a.	ORG
fnp-2627	249	2	s.	GPE
fnp-2627	249	3	adam	GPE
fnp-2627	249	4	d.	NORP
fnp-2627	249	5	chughtai	GPE
fnp-2627	249	6	a.a.	GPE
fnp-2627	249	7	macintyre	GPE
fnp-2627	249	8	c.r.	GPE
fnp-2627	249	9	2018	DATE
fnp-2627	251	1	euro surveill 23	DATE
fnp-2627	252	1	l.	GPE
fnp-2627	252	2	amelin	GPE
fnp-2627	252	3	d.	NORP
fnp-2627	252	4	w.	PERSON
fnp-2627	252	5	corneau, a.	ORG
fnp-2627	252	6	blanc	GPE
fnp-2627	252	7	c.	GPE
fnp-2627	252	8	2019	CARDINAL
fnp-2627	254	1	autoimmun rev	PERSON
fnp-2627	254	2	18	CARDINAL
fnp-2627	254	3	325	CARDINAL
fnp-2627	255	1	fischer	ORG
fnp-2627	255	2	j.	PERSON
fnp-2627	255	3	d.	NORP
fnp-2627	255	4	von casteleyn	PERSON
fnp-2627	255	5	hahn	PERSON
fnp-2627	255	6	k.	PERSON
fnp-2627	255	7	2019	DATE
fnp-2627	256	1	sequestosome-1	PERSON
fnp-2627	258	1	gonorazky	ORG
fnp-2627	258	2	h.d.	GPE
fnp-2627	258	3	s.	PERSON
fnp-2627	258	4	ramani	NORP
fnp-2627	258	5	a.k.	GPE
fnp-2627	258	6	nelakuditi	ORG
fnp-2627	258	7	mashouri	GPE
fnp-2627	258	8	wang	PERSON
fnp-2627	258	9	kao	PERSON
fnp-2627	258	10	d.	NORP
fnp-2627	258	11	k.	PERSON
fnp-2627	258	12	viththiyapaskaran	GPE
fnp-2627	258	13	s., tarnopolsky	ORG
fnp-2627	258	14	m.a.	PERSON
fnp-2627	258	15	2019	DATE
fnp-2627	260	1	j hum genet	PERSON
fnp-2627	260	2	104	CARDINAL
fnp-2627	260	3	466	CARDINAL
fnp-2627	261	1	greenberg	PERSON
fnp-2627	261	2	s.a.	GPE
fnp-2627	261	3	pinkus	GPE
fnp-2627	261	4	j.l.	GPE
fnp-2627	261	5	kong	GPE
fnp-2627	261	6	s.w.	GPE
fnp-2627	261	7	baecher-allan	PERSON
fnp-2627	261	8	a.a.	GPE
fnp-2627	261	9	2019	DATE
fnp-2627	263	1	142	CARDINAL
fnp-2627	263	2	2590-2604	DATE
fnp-2627	264	1	hixon	PERSON
fnp-2627	264	2	yu	PERSON
fnp-2627	264	3	leser	PERSON
fnp-2627	264	4	j.s.	GPE
fnp-2627	264	5	s.	GPE
fnp-2627	264	6	clarke	GPE
fnp-2627	264	7	chiu	PERSON
fnp-2627	264	8	c.y.	GPE
fnp-2627	264	9	k.l.	GPE
fnp-2627	264	10	2017	CARDINAL
fnp-2627	266	1	plos pathog	PERSON
fnp-2627	266	2	13	DATE
fnp-2627	267	1	hwang	PERSON
fnp-2627	267	2	j.	PERSON
fnp-2627	267	3	yokota	GPE
fnp-2627	267	4	t.	GPE
fnp-2627	267	5	2019	CARDINAL
fnp-2627	269	1	rev mol med	PERSON
fnp-2627	269	2	21	DATE
fnp-2627	270	1	johansen	PERSON
fnp-2627	270	2	a.	PERSON
fnp-2627	270	3	christensen	PERSON
fnp-2627	270	4	s.j.	PERSON
fnp-2627	270	5	scheie	ORG
fnp-2627	270	6	d.	NORP
fnp-2627	270	7	hojgaard, j.l.s.	PERSON
fnp-2627	270	8	2019	DATE
fnp-2627	272	1	92	CARDINAL
fnp-2627	272	2	663	CARDINAL
fnp-2627	273	1	kabeya	GPE
fnp-2627	273	2	t.,	GPE
fnp-2627	273	3	yonezawa	GPE
fnp-2627	273	4	s.	GPE
fnp-2627	273	5	takeuchi	GPE
fnp-2627	273	6	nagisa	PERSON
fnp-2627	273	7	inoue	PERSON
fnp-2627	273	8	m.	PERSON
fnp-2627	273	9	r.	NORP
fnp-2627	273	10	ozawa	GPE
fnp-2627	273	11	i.	PERSON
fnp-2627	273	12	2019	DATE
fnp-2627	275	1	29	CARDINAL
fnp-2627	276	1	s.	PERSON
fnp-2627	276	2	leonard-louis	PERSON
fnp-2627	276	3	s.	GPE
fnp-2627	276	4	touat	ORG
fnp-2627	276	5	m.	PERSON
fnp-2627	276	6	fischer	PERSON
fnp-2627	276	7	n.	ORG
fnp-2627	276	8	mothes	PERSON
fnp-2627	276	9	r.	NORP
fnp-2627	276	10	w.	PERSON
fnp-2627	277	1	2019	DATE
fnp-2627	279	1	neurol neuroimmunol	PERSON
fnp-2627	279	2	6	DATE
fnp-2627	280	1	lornage	PERSON
fnp-2627	280	2	x.	GPE
fnp-2627	280	3	schartner	PERSON
fnp-2627	280	4	i.	GPE
fnp-2627	280	5	willis	PERSON
fnp-2627	280	6	t.	GPE
fnp-2627	280	7	a.	GPE
fnp-2627	280	8	s.	ORG
fnp-2627	280	9	r., fardeau	GPE
fnp-2627	280	10	m., malfatti	GPE
fnp-2627	280	11	e.	PERSON
fnp-2627	280	12	2019	DATE
fnp-2627	282	1	138	CARDINAL
fnp-2627	283	1	margeta	PERSON
fnp-2627	283	2	m.	PERSON
fnp-2627	283	3	2019	DATE
fnp-2627	285	1	annu rev	ORG
fnp-2627	286	1	k.	PERSON
fnp-2627	286	2	asturias	GPE
fnp-2627	286	3	e.j.	GPE
fnp-2627	286	4	hixon	PERSON
fnp-2627	286	5	van leer-buter	PERSON
fnp-2627	286	6	tyler	GPE
fnp-2627	286	7	k.l.	GPE
fnp-2627	286	8	abzug	ORG
fnp-2627	286	9	m.j.	PERSON
fnp-2627	286	10	dominguez	GPE
fnp-2627	286	11	s.r.	GPE
fnp-2627	286	12	2018	DATE
fnp-2627	288	1	lancet	ORG
fnp-2627	288	2	18	CARDINAL
fnp-2627	289	1	r.	NORP
fnp-2627	289	2	ivanyi	GPE
fnp-2627	289	3	i.	PERSON
fnp-2627	289	4	2019	CARDINAL
fnp-2627	290	1	ipilimumab	PERSON
fnp-2627	291	1	j clin med	PERSON
fnp-2627	291	2	8	CARDINAL
fnp-2627	292	1	montagnese	NORP
fnp-2627	292	2	f.	PERSON
fnp-2627	292	3	babacic, h.	ORG
fnp-2627	292	4	b.	PERSON
fnp-2627	292	5	2019	DATE
fnp-2627	294	1	j neurol 266	PERSON
fnp-2627	294	2	1358-1366	DATE
fnp-2627	295	1	m., engvall	PERSON
fnp-2627	295	2	m., ravenscroft	PERSON
fnp-2627	295	3	g.	PERSON
fnp-2627	295	4	cabrera	PERSON
fnp-2627	295	5	m., jiao, h.	PERSON
fnp-2627	295	6	c.a.	GPE
fnp-2627	295	7	m., jiang, h.	PERSON
fnp-2627	295	8	forrest	PERSON
fnp-2627	295	9	2019	DATE
fnp-2627	296	1	myoglobinopathy	PERSON
fnp-2627	297	1	nat commun 10, 1396	ORG
fnp-2627	298	1	pinal-fernandez	ORG
fnp-2627	298	2	i.	PERSON
fnp-2627	298	3	casal-dominguez	ORG
fnp-2627	298	4	m., derfoul	GPE
fnp-2627	298	5	a.	GPE
fnp-2627	298	6	pak	ORG
fnp-2627	298	7	k.	PERSON
fnp-2627	298	8	miller	GPE
fnp-2627	298	9	f.w.	GPE
fnp-2627	298	10	j.c.	PERSON
fnp-2627	298	11	grau-junyent	PERSON
fnp-2627	298	12	j.m.	GPE
fnp-2627	298	13	selva-o'callaghan	PERSON
fnp-2627	298	14	paik	ORG
fnp-2627	298	15	j.	PERSON
fnp-2627	298	16	2019	DATE
fnp-2627	300	1	93	DATE
fnp-2627	301	1	psimaras	PERSON
fnp-2627	301	2	d.	NORP
fnp-2627	301	3	velasco	GPE
fnp-2627	301	4	r.	NORP
fnp-2627	301	5	s.	GPE
fnp-2627	301	6	lustberg	GPE
fnp-2627	301	7	m., bruna	PERSON
fnp-2627	301	8	j.	PERSON
fnp-2627	301	9	argyriou, a.a.	ORG
fnp-2627	301	10	2019	DATE
fnp-2627	303	1	nerv syst	PERSON
fnp-2627	303	2	24	CARDINAL
fnp-2627	304	1	2	CARDINAL
fnp-2627	304	2	ramos	PERSON
fnp-2627	304	3	d.m.	PERSON
fnp-2627	304	4	d'ydewalle	GPE
fnp-2627	304	5	dakka, a.	ORG
fnp-2627	304	6	klein	GPE
fnp-2627	304	7	s.k.	GPE
fnp-2627	304	8	norris	ORG
fnp-2627	304	9	d.a.	GPE
fnp-2627	304	10	matson	PERSON
fnp-2627	304	11	j., taylor	ORG
fnp-2627	304	12	s.j.	PERSON
fnp-2627	304	13	zaworski	PERSON
fnp-2627	304	14	p.g.	GPE
fnp-2627	304	15	t.w.	GPE
fnp-2627	304	16	2019	DATE
fnp-2627	306	1	j clin	PERSON
fnp-2627	306	2	129	CARDINAL
fnp-2627	306	3	4817-4831	DATE
fnp-2627	307	1	reyes-fernandez	PERSON
fnp-2627	307	2	p.c.	GPE
fnp-2627	307	3	x.	GPE
fnp-2627	307	4	f.	PERSON
fnp-2627	307	5	2019	CARDINAL
fnp-2627	309	1	9	CARDINAL
fnp-2627	309	2	15	DATE
fnp-2627	310	1	m., hou	PERSON
fnp-2627	310	2	baba amer	PERSON
fnp-2627	310	3	j., periou	ORG
fnp-2627	310	4	r.k.	GPE
fnp-2627	310	5	2019	CARDINAL
fnp-2627	312	1	rmd	PERSON
fnp-2627	312	2	5	CARDINAL
fnp-2627	313	1	ross	PERSON
fnp-2627	313	2	j.a.	GPE
fnp-2627	313	3	m.	PERSON
fnp-2627	313	4	kolb	GPE
fnp-2627	313	5	j.s.	GPE
fnp-2627	313	6	turmaine	GPE
fnp-2627	313	7	m., holt	PERSON
fnp-2627	313	8	m.	PERSON
fnp-2627	313	9	j., claeys	PERSON
fnp-2627	313	10	k.g.	GPE
fnp-2627	313	11	weis	PERSON
fnp-2627	313	12	j.	GPE
fnp-2627	313	13	m.	PERSON
fnp-2627	313	14	2019	DATE
fnp-2627	314	1	nemaline myopathy	LOC
fnp-2627	315	1	138	CARDINAL
fnp-2627	315	2	477	CARDINAL
fnp-2627	316	1	schubert	PERSON
fnp-2627	316	2	r.d.	GPE
fnp-2627	316	3	hawes	GPE
fnp-2627	316	4	i.a.	GPE
fnp-2627	316	5	ramachandran	PERSON
fnp-2627	316	6	p.s.	PERSON
fnp-2627	316	7	crawford	GPE
fnp-2627	316	8	e.d.	GPE
fnp-2627	316	9	pak	ORG
fnp-2627	316	10	j.e.	GPE
fnp-2627	316	11	wu	PERSON
fnp-2627	316	12	w.	PERSON
fnp-2627	316	13	cheung	GPE
fnp-2627	316	14	c.k.	GPE
fnp-2627	316	15	b.d.	GPE
fnp-2627	316	16	c.m.	GPE
fnp-2627	316	17	2019	DATE
fnp-2627	318	1	nat	ORG
fnp-2627	318	2	25	DATE
fnp-2627	318	3	1748-1752	DATE
fnp-2627	319	1	sloan	ORG
fnp-2627	319	2	e.a.	GPE
fnp-2627	319	3	sampognaro	ORG
fnp-2627	319	4	p.j.	GPE
fnp-2627	319	5	junn	GPE
fnp-2627	319	6	j.c.	GPE
fnp-2627	319	7	chin	PERSON
fnp-2627	319	8	jacques	PERSON
fnp-2627	319	9	l.	GPE
fnp-2627	319	10	ramachandran	PERSON
fnp-2627	319	11	p.s.	PERSON
fnp-2627	319	12	derisi	ORG
fnp-2627	319	13	j.l.	GPE
fnp-2627	319	14	wilson	GPE
fnp-2627	319	15	m.r.	GPE
fnp-2627	319	16	a.r.	GPE
fnp-2627	319	17	bollen	ORG
fnp-2627	319	18	a.w.	GPE
fnp-2627	320	1	2019	DATE
fnp-2627	322	1	138	CARDINAL
fnp-2627	322	2	1103-1106	DATE
fnp-2627	323	1	tanboon	TIME
fnp-2627	323	2	j.	PERSON
fnp-2627	323	3	nishino	GPE
fnp-2627	323	4	i.	PERSON
fnp-2627	323	5	2019	DATE
fnp-2627	325	1	curr opin	PERSON
fnp-2627	325	2	neurol 32	ORG
fnp-2627	325	3	704	CARDINAL
fnp-2627	326	1	touat	ORG
fnp-2627	326	2	m.	PERSON
fnp-2627	326	3	maisonobe	PERSON
fnp-2627	326	4	t., knauss	PERSON
fnp-2627	326	5	s.	PERSON
fnp-2627	326	6	ben hadj	PERSON
fnp-2627	326	7	k.	PERSON
fnp-2627	326	8	t.a.	GPE
fnp-2627	326	9	kramkimel	PERSON
fnp-2627	326	10	n.	PERSON
fnp-2627	326	11	c., bruch	GPE
fnp-2627	326	12	j.f.	GPE
fnp-2627	326	13	2018	DATE
fnp-2627	328	1	91	CARDINAL
fnp-2627	328	2	k.	PERSON
fnp-2627	328	3	schwartz	GPE
fnp-2627	328	4	blaschek	GPE
fnp-2627	328	5	a.	PERSON
fnp-2627	328	6	s.	PERSON
fnp-2627	328	7	w.	PERSON
fnp-2627	328	8	j., glaser	PERSON
fnp-2627	328	9	d.	NORP
fnp-2627	329	1	2019	DATE
fnp-2627	330	1	one year	DATE
fnp-2627	330	2	german	NORP
fnp-2627	331	1	6	CARDINAL
fnp-2627	331	2	503	CARDINAL
fnp-2627	332	1	villar-quiles	PERSON
fnp-2627	332	2	r.n.	GPE
fnp-2627	332	3	f.	PERSON
fnp-2627	332	4	cabet	GPE
fnp-2627	332	5	e.	GPE
fnp-2627	332	6	juntas	NORP
fnp-2627	332	7	r.	NORP
fnp-2627	332	8	c.a.	GPE
fnp-2627	332	9	gidaro	PERSON
fnp-2627	332	10	t.	GPE
fnp-2627	332	11	koparir	NORP
fnp-2627	332	12	a.	PERSON
fnp-2627	332	13	coppens	GPE
fnp-2627	332	14	s.	PERSON
fnp-2627	332	15	deconinck	GPE
fnp-2627	332	16	2019	CARDINAL
fnp-2627	333	1	asc-1	PERSON
fnp-2627	334	1	ann neurol	PERSON
fnp-2627	335	1	j., johnson	PERSON
fnp-2627	335	2	k.	PERSON
fnp-2627	335	3	a.	PERSON
fnp-2627	335	4	nafissi, s.	PERSON
fnp-2627	335	5	diaz-manera	PERSON
fnp-2627	335	6	j.	GPE
fnp-2627	335	7	french	NORP
fnp-2627	335	8	v.m.	GPE
fnp-2627	335	9	schindler	ORG
fnp-2627	335	10	r.f.	GPE
fnp-2627	335	11	sarathchandra	GPE
fnp-2627	335	12	rinne, s.	ORG
fnp-2627	336	1	2019	DATE
fnp-2627	337	1	popdc3	PERSON
fnp-2627	338	1	ann neurol 86	PERSON
fnp-2627	338	2	832	CARDINAL
fnp-2627	339	1	g., vita	PERSON
fnp-2627	339	2	g.l.	GPE
fnp-2627	339	3	rodolico	GPE
fnp-2627	339	4	messina	GPE
fnp-2627	339	5	s.	PERSON
fnp-2627	339	6	2019	DATE
fnp-2627	341	1	2	CARDINAL
fnp-2627	342	1	neurol sci 40	PERSON
fnp-2627	342	2	671-681	CARDINAL
fnp-2627	343	1	2020	DATE
fnp-2627	344	1	4.0	CARDINAL
fnp-2627	344	2	https://creativecommons.org/licenses/by/4.0/	WORK_OF_ART